New Technote – Batch-to-Batch Consistency of CellGenix® GMP Cytokines
We confirmed that the batch-to-batch consistency of our CellGenix® GMP cytokines is very high
Inconsistent product performance of raw materials causes deviations in the cell therapy manufacturing process. It is unlikely that you will be able to use the same raw materials batch during all stages from early clinical studies to commercial manufacturing. It is therefore crucial to choose GMP raw materials with a high and reliable batch-to-batch consistency. This will allow you to plan your manufacturing process as accurately as possible and save time and cost of goods on incoming controls and revalidations.
To make sure your manufacturing process is not influenced by using different batches of GMP cytokines, we have performed batch-to-batch consistency studies for our key CellGenix® GMP cytokines. These studies demonstrate that our batch-to-batch consistency is very high over the full range of production.
Please download the Technote to have a detailed overview of our batch-to-batch consistency studies.